Ingen Technologies Interest Coverage
Interest Coverage Ratio of Ingen Technologies (IGNT) as of Aug 11, 2026.
Get this data via API
Financial Data API
Interest Coverage
0.00
Last updated:
Interest Coverage Ratio of Ingen Technologies is 2026 0.00 . Interest Coverage Ratio of Ingen Technologies was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Ingen Technologies Stock analysis
What does Ingen Technologies do? Ingen Technologies Inc is an American company specializing in the development and marketing of medical devices and solutions. The company was founded in 1999 by Scott R. Sand and other industry experts and is headquartered in Riverside, California.
The history of Ingen Technologies Inc began with the goal of developing innovative and efficient products for the healthcare sector. The company focused on the development of medical devices that improve patient monitoring and treatment while also reducing healthcare costs.
The business model of Ingen Technologies Inc is based on the development and marketing of products used in various sectors. The company specializes in the manufacture of medical devices and solutions that utilize technology to support hospitals and other healthcare facilities.
The various sectors in which Ingen Technologies Inc operates include diagnostics, monitoring, treatment, and patient care. The company has developed a wide range of medical devices and solutions, including infusion pumps, blood pressure monitors, medical monitoring systems, and more.
One of the key products of Ingen Technologies Inc is the SmartCheck™ Blood Glucose Monitoring System. This innovative system is used by patients with diabetes to monitor and control their blood sugar levels. The device is user-friendly and provides accurate results that contribute to improved patient management.
Another important product of Ingen Technologies Inc is the SmartPump® Infusion System. This system is used by medical professionals to administer medications and other substances that require precise dosing. The SmartPump® Infusion System reduces the risk of medication errors and ensures greater precision in medication administration.
Ingen Technologies Inc also has a strong presence in the air purification field, particularly in hospitals and other healthcare facilities. The company offers a wide range of air purification devices that remove viruses, bacteria, and other microorganisms, improving air quality in medical facilities.
Overall, Ingen Technologies Inc has established itself as a leading company in the medical device industry. The company has distinguished itself through its commitment to innovative and effective solutions and has developed a wide range of products used in medical facilities and clinics worldwide.
At Ingen Technologies Inc, the health and well-being of people are at the forefront of their activities. The company is dedicated to improving medical care for all while also reducing healthcare costs. Through the development and marketing of medical devices and solutions that leverage technology, Ingen Technologies Inc has made a significant contribution to improving patient care. Ingen Technologies is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Ingen Technologies stock
On Eulerpool you can find the complete historical development of Interest Coverage Ratio Ingen Technologies since 2006 – with annual values, charts, and detailed analysis.
The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.
Interest Coverage = EBIT / Interest Expense
A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Ingen Technologies with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
Leverage — Ingen Technologies
All Key Metrics — Ingen Technologies
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth